SERPINA4 and Sepsis: In mouse models of polymicrobial sepsis and endotoxemia, delayed administration of recombinant human kallistatin significantly increased the survival rate of mice and reduced key pro-inflammatory mediators (TNF-α, IL-6, and HMGB1) in the serum (4).